NR3C2 and acute myeloid leukemia: AML mutations were also prevalent in B cells and NK cells (but not T cells) in a small subset of AMLs from the AML-MR or TP53 subtypes, indicating a less restrictive lineage block or the presence of mutated pre-leukemic cells with intact lymphoid potential, at least in individual cases (Fig. 3d).